Posted by Michael Wonder on 25 Nov 2020
Russia looks to undercut rivals with cut-price COVID-19 vaccine
24 November 2020 - Phase 3 trials showed the jab was 91.4% effective in protecting people from COVID-19.
Russia will sell its Sputnik V coronavirus vaccine internationally for under $10 a dose, a lower price than some Western-developed shots, as Moscow looks to gain economic and political leverage abroad by exporting its fast-tracked jab.
